VEEVA SYSTEMS INC-CLASS A

Veeva Systems boosts Q2 2026 earnings and $883 M revenue, unveiling AI‑powered Falcon and Vault Agents to slash drug‑dev cycle times and boost regulatory compliance. Explore the future of cloud‑native life‑science software.

Veeva Systems’ high‑margin cloud platform boosts pharma efficiency and early payer access, while its strong cash flow and low debt give investors confidence in growth and tech‑healthcare leadership.